Clinical Trial Update: Long Duration Holter ECG in Fabry Disease [NA]

View source ↗

Summary

A clinical trial sponsored by INSERM is evaluating long-duration Holter ECG monitoring in Fabry disease and is currently recruiting in France.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Fabry Disease | NA | Status: RECRUITING